🔎 Trials Near Me

Hjem › Diffust stort B-celle lymfom › Indiana › Indianapolis

Diffust stort B-celle lymfom kliniske forsøg i Indianapolis, IN

7 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Indianapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

RekruttererFase 2
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

RekruttererFase 2
  • Saint Catherine Hospital, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

RekruttererFase 3
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06091865

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RekruttererFase 1/2
  • Indiana Blood and Marrow Transplantation, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

RekruttererFase 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 10. jul. 2026 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

RekruttererFase 2
  • Saint Catherine Hospital, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 20. okt. 2025 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RekruttererFase 2
  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Alder 18 og opefter · Alle køn · Opdateret 7. apr. 2023 · NCT04920617

Diffust stort B-celle lymfom forsøg i andre byer

Andre studier i Indianapolis

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.